Clonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neurons

Neuropeptides

Volumn 31, Issue 3, 1997, Pages 203-207

  Smialowska M ^a   Obuchowicz, E ^b   Turchan, J ^a   Herman, Z S ^b   Przewlocki R ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; NEUROPEPTIDE Y;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 0030808117     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90049-4     Document Type: Article

References (36)

1. Gray T S, Morley J E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci 1986; 38: 389-401.
2. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659-660.
3. Chronwall B M. Anatomical distribution of NPY and NPY messenger RNA in rat brain. In: Neuropeptide Y, Eds Mutt V, Fuxe K, Hokfelt T, Lundberg J M. Raven Press: New York, 1989: 51-59.
4. Danger J M, Tonon M C, Jenks B G et al. Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fund Clin Pharmacol 1990; 4: 307-340
5. Aoki C, Pickel V M. Neuropeptide Y in the cerebral cortex and the caudate-putamen nuclei: ultrastructural basis for interactions with GABAergic and non-GABAergic neurons. J Neurosci 1989; 9: 4333-4354.
6. Nakagawa Y, Shiosaka S, Emson P C, Tohyama M. Distribution of neuropeptide Y in the forebrain and diencephalon; an immunohistochemical analysis. Brain Res 1985; 361: 52-60.
7. Wahlestedt C, Ekmen R, Widerlov E. Neuropeptide Y (NPY) and central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders. Prog Neuro-Psychopharmacol Biol Psychiat 1989; 13: 31-54.
8. Dahlof C, Dahlof P, Tatemoto K, Lundberg J M. Neuropeptide Y (NPY) reduces field stimulation evoked release of noradrenaline and enhances force of contraction in the rat portal vein. Naunyn-Schmiedeberg's Arch Pharmacol 1985; 328: 327-330.
9. Evequoz D, Grouzmann E, Nussberger J, Niederberger M, Brunner H R, Waeber B. Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats. Reg Pept 1995; 58: 163-166.
10. 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand 1984; 120: 477-479.
11. Wahlestedt C, Grundemar L, Hakanson et al. Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 1990; 611: 7-26.
12. 2 type. Eur J Pharmacol 1993; 230: 231-234.
13. Pavia J M, Hastings J A, Morris M J. Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo. Brain Res 1995; 690: 108-111.
14. Kerkerian L, Salin P, Nieoullon A. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Neuroscience 1988; 26: 809-817.
15. Salin P, Kerkerian L, Nieoullon A. Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway. Exp Brain Res 1990; 81: 363-371.
16. Śmiałowska M, Legutko, B. Haloperidol-induced increase in neuropeptide Y immunoreactivity in the locus coeruleus of the rat brain. Neuroscience 1992; 47: 351-355.
17. Śmiałowska M. An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons. Neuroscience 1995; 66: 589-595.
18. Fuxe K, Hamberger B, Hokfelt T. Distribution of noradrenaline nerve terminals in cortical areas of the rat. Brain Res 1968; 8: 125-131.
19. Swanson L W, Hartman B K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-B-hydroxylase as a marker. J Comp Neurol 1975; 163: 467-506.
20. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 1971; suppl. 367: 1-48.
21. Tsuchiyama M, Kubota Y, Sugita M, Usuda S, Yamano M, Tohyama M. Direct synaptic contracts of catecholamine fibers on neuropeptide Y-containing neurons of the rat cerebral cortex. Brain Res 1989; 494: 168-171.
22. Illes P, Regenold J T. Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons. Nature 1990; 344: 62-63.
23. 2-adrenoceptor-mediated cardiovascular responses in the pithed rat. Br J Pharmacol 1990; 100: 840-842.
24. 2 adrenergic binding sites in membranes of the medulla oblongata. Acta Physiol Scand 1983; 118: 293-295.
25. Fuxe K, Agnati L F, Harfstrand A et al. Central administration of neuropeptide Y induces hypotension, bradypnea and EEG synchronisation in the rat. Acta Physiol Scand 1983; 118: 189-192.
26. 2-Adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. Eur J Pharmacol 1986; 131: 279-283.
27. Franco-Cereceda A, Nagata M, Svensson T H, Lundberg J M. Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig. Eur J Pharmacol 1987; 142: 267-273.
28. Nagata M, Franco-Cereceda A, Svensson T H, Lundberg J M. Clonidine treatment elevates content of neuropeptide Y in cardiac nerves. Acta Physiol Scand 1986; 128: 321-322.
29. 2-adrenoceptor agonist, clonidine. Br J Pharmacol 1991; 103: 1136-1140.
30. Wamsley J K, Palacios J M, Young III W S, Kuhar M J. Autoradiographic determination of neurotransmitter receptor distribution in the cerebral and cerebellar cortices. J Histochem Cytochem 1981; 29: 125-135.
31. 2 receptors: Light microscopic autoradiographic localization. Proc Natl Acad Sci USA 1980; 77: 1696-1700.
32. Allen J M, Yeats J C, Adrian T E, Bloom S R. Radioimmunoassay of neuropeptide Y. Regul Pept 1984; 8: 61-70.
33. Warner M R, Senanayake P S, Ferrario C M, Levy M N. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. Circ Res 1991; 69: 455-465.
34. Hsu S M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
35. Young III W S, Bonner T I, Brann M R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 1986; 83: 9827-9831.
36. Audet M A, Doucet G, Oleskevich S, Descarries L. Quantified regional and laminar distribution of the noradrenaline innervation in the anterior half of the adult rat cerebral cortex. J Comp Neurol 1988; 274: 307-318.